Recombinant multi-species Thyroglobulin/TG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Thyroglobulin/TG protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Thyroglobulin (Tg) is a glycoprotein homodimer produced predominantly by the thryroid gland. It acts as a substrate for the synthesis of thyroxine and triiodothyronine as well as the storage of the inactive forms of thyroid hormone and iodine. Thyroglobulin is secreted from the endoplasmic reticulum to its site of iodination, and subsequent thyroxine biosynthesis, in the follicular lumen. Mutations in this gene cause thyroid dyshormonogenesis, manifested as goiter, and are associated with moderate to severe congenital hypothyroidism. Polymorphisms in this gene are associated with susceptibility to autoimmune thyroid diseases (AITD) such as Graves disease and Hashimoto thryoiditis. [provided by RefSeq, Nov 2009]
The Alternative Names of target: AITD3,TG,TGN,Tg,Tgn,Thyroglobulin,cog
Go
to Thyroglobulin/TG products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1335-Ag-1/ GM-Tg-hg-SE1335-Ag-2 | Human Thyroglobulin/TG protein | Human |
| GM-Tg-rg-SE1335-Ag-1/ GM-Tg-rg-SE1335-Ag-2 | Rat Thyroglobulin/TG protein | Rat |
| GM-Tg-mg-SE1335-Ag-1/ GM-Tg-mg-SE1335-Ag-2 | Mouse Thyroglobulin/TG protein | Mouse |
| GM-Tg-cynog-SE1335-Ag-1/ GM-Tg-cynog-SE1335-Ag-2 | Cynomolgus/Rhesus macaque Thyroglobulin/TG protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1335-Ag-1/ GM-Tg-felg-SE1335-Ag-2 | Feline Thyroglobulin/TG protein | Feline |
| GM-Tg-cang-SE1335-Ag-1/ GM-Tg-cang-SE1335-Ag-2 | Canine Thyroglobulin/TG protein | Canine |
| GM-Tg-bovg-SE1335-Ag-1/ GM-Tg-bovg-SE1335-Ag-2 | Bovine Thyroglobulin/TG protein | Bovine |
| GM-Tg-equg-SE1335-Ag-1/ GM-Tg-equg-SE1335-Ag-2 | Equine Thyroglobulin/TG protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1335-Ag-1/ GM-Tg-hg-SE1335-Ag-2;
GM-Tg-rg-SE1335-Ag-1/ GM-Tg-rg-SE1335-Ag-2;
GM-Tg-mg-SE1335-Ag-1/ GM-Tg-mg-SE1335-Ag-2; GM-Tg-cynog-SE1335-Ag-1/ GM-Tg-cynog-SE1335-Ag-2; GM-Tg-felg-SE1335-Ag-1/ GM-Tg-felg-SE1335-Ag-2; GM-Tg-cang-SE1335-Ag-1/ GM-Tg-cang-SE1335-Ag-2; GM-Tg-bovg-SE1335-Ag-1/ GM-Tg-bovg-SE1335-Ag-2; GM-Tg-equg-SE1335-Ag-1/ GM-Tg-equg-SE1335-Ag-2 |
| Products Name | Thyroglobulin/TG protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Thyroglobulin/TG |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Thyroglobulin/TG protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.